doi:

DOI: 10.3724/SP.J.1008.2009.00442

Academic Journal of Second Military Medical University (第二军医大学学报) 2009/29:4 PP.442-446

Prenatal diagnosis value of free fetal DNA in maternal blood


Abstract:
The discovery of circulating fetal DNA paves a new way for non-invasive prenatal diagnosis. Examining the specific fetal DNA sequence of the circulating fetal DNA has been used for prenatal diagnosis of sex-linked disorders, fetal rhesus D blood typing and single gene inheritance disease. The variation of the circulating DNA levels can also be used for diagnosis of preeclampsia, premature delivery, and fetal chromosome disorders. This paper aims to review the biochemistry characters and clinical application of the circulating fetal DNA in maternal peripheral plasma.

Key words:cell-free fetal DNA,circulating nucleic acid,non-invasive prenatal diagnosis,gene diagnosis,maternal blood

ReleaseDate:2014-07-21 14:36:59

Funds:Supported by the National Key Technology R D Program of China (2006BAI05A05).



[1] Hahn S, Zhong X Y, Holzgreve W. Recent progress in non-invasive prenatal diagnosis[J]. Semin Fetal Neonatal Med, 2008, 13:57-62.

[2] Leon S A, Shapiro B, Sklaroff D M, Yaros M J. Free DNA in the serum of cancer patients and the effect of therapy[J]. Cancer Res, 1977, 37:646-650.

[3] Lo Y M, Corbetta N, Chamberlain P F, Rai V, Sargent I L, Redman C W, et al. Presence of fetal DNA in maternal plasma and serum[J]. Lancet, 1997, 350485-350487.

[4] Lo Y M, Zhang J, Leung T N, Lau T K, Chang A M, Hjelm N M. Rapid clearance of fetal DNA from maternal plasma[J]. Am J Hum Genet, 1999, 64:218-224.

[5] Hyodo M,Samura O, Fujito N, Tanigawa M, Miyoshi H, Fujiwra H, et al. No correlation between the number of fetal nucleated cells and the amount of cell-free fetal DNA in maternal circulation either before or after delivery[J]. Prenat Diagn, 2007, 27:717-721.

[6] Hahn S, Chitty L S. Noninvasive prenatal diagnosis: current practice and future perspectives[J]. Curr Opin Obstet Gynecol, 2008, 20:146-151.

[7] Bischoff F Z, Lewis D E, Simpson J L. Cell free fetal DNA in maternal blood: kinetics,source and tructure[J]. Hum Reprod Update, 2005, 11:59-67.

[8] Chan K C, Zhang J, Hui A B, Wong N, Lau T K, Leung T N, et al. Size distributions of maternal and fetal DNA in maternal plasma[J]. Clin Chem, 2004, 50:88-92.

[9] Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms[J]. Clin Chem, 2004, 50:1002-1011.

[10] Lo Y M, Tein M S, Lau T K, Haines C J, Leung T N, Poon P M, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis[J]. Am J Hum Genet, 1998, 62:768-775.

[11] Rijnders R J, van der Luijt R B, Peters E D, Goeree J K, Van Der Schoot C E, Ploos Van Amstel J K, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma[J]. Prenat Diagn, 2003, 23:1042-1044.

[12] Chan L Y, Leung T N, Chan K C, Tai H L, Lau T K, Wong E M, et al. Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy[J]. Clin Chem, 2003, 49:678-680.

[13] Illanes S, Denbow M, Kailasam C, Finning K, Soothill P W. Early detection of cell-free fetal DNA in maternal plasma[J]. Early Hum Dev, 2007, 83:563-566.

[14] Horinek A,Korabecna M, Panczak A,Ulcova Gallova Z, Nouzova K, Calda P, et al. Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: methodology issues and kinetics[J]. Fetal Diagn Ther, 2008, 24:15-21.

[15] Angert R M, LeShane E S, Lo Y M, Chan L Y, Delli-Bovi L C, Bianchi D W. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection analysis of first and third-trimester samples[J]. Clin Chem, 2003, 49:195-198.

[16] Lam N Y, Rainer T H, Chiu R W, Lo Y M. EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis[J]. Clin Chem, 2004, 50:256-257.

[17] Zhang Y, Li Q, Hui N, Fei M, Hu Z, Sun S. Effect of formaldehyde treatment on the recovery of cell-free fetal DNA from maternal plasma at different processing times[J]. Clin Chim Acta, 2008, 397:60-64.

[18] Chim S S, Tong Y K, Chiu R W, Lau T K, Leung T N, Chan L Y, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma[J]. Proc Natl Acad Sci USA, 2005, 102:14753-14758.

[19] Finning K M, Chitty L S. Non-invasive fetal sex determination: Impact on clinical practice[J]. Semin Fetal Neonatal Med, 2008, 13:69-75.

[20] Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum[J]. Hum Genet, 2002, 110:75-79.

[21] Bartha J L, Finning K, Soothill P W. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency[J]. Obstet Gynecol, 2003, 101(5 Pt 2):1135-1136.

[22] Van der Schoot C E, Soussan A A, Koelewijn J, Bonsel G, Paget-Christiaens L G, de Haas M. Non-invasive antenatal RHD typing[J]. Transfus Clin Biol, 2006, 13:53-57.

[23] Daniels G, Finning K, Martin P, Summers J. Fetal RhD genotyping: A more efficient use of anti-D immunoglobulin[J]. Transfus Clin Biol, 2007, 14:568-571.

[24] Lo Y M, Hjelm N M, Fidler C, Sargent I L, Murphy M F, Chamberlain P F, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma[J]. N Engl J Med, 1998, 339:1734-1738.

[25] Geifman-Holtzman O, Grotegut C A, Gaughan J P. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood:a meta-analysis[J]. Am J Obstet Gynecol, 2006, 195:1163-1173.

[26] Chinena P A, Nardozzaa L M M, Camanoa L, Morona A F, Paresa D B S, Martinhagob C D, et al. Non-invasive fetal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative Brazilian pregnant women[J]. J Reprod Immunol, 2007, 75:A8-A9.

[27] Sibai B, Dekker G, Kupferminc M. Pre-eclampsia[J]. Lancet, 2005, 365:785-799.

[28] Engel K, Plonka T, Bilar M, Orzinska A, Brojer E, Ronin-Walknowska E. The correlation between clinical characteristics of preeclampsia and the concentration of fetal DNA in maternal circulation[J]. Eur J Obstet Gynecol Reprod Biol, 2008, 139:256-257.

[29] Lau T W, Leung T N, Chan L Y, Lau T K, Chan K C, Tam W H, et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia[J]. Clin Chem, 2002, 48:2141-2146.

[30] Go A T J I, Visser A, Mulders M A M, Westerman B A, Blankenstein M A, Oudejans C B M, et al. First-trimester fetal mRNA of placental origin in maternal plasma[J]. Am J Obstet Gynecol, 2003, 6:S111.

[31] Lau T K, Lo K W, Chan L Y, Leung T Y, Lo Y M. Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term[J]. Amr J Obstet Gynecol, 2000, 183:712-716.

[32] Tong Y K, Ding C M, Chiu R W K, Gerovassili A, Chim S S C, Leung T Y, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations[J]. Clin Chem, 2006, 52:2194-2202.

[33] Hultén M A,Old R W. Non-invasive prenatal diagnosis of Down's syndrome[J]. Lancet, 2007,369:1997.

[34] Galbiati S, Foglieni B, Travi M, Curcio C, Restagno G, Sbaiz L, et al. Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of beta-thalassemia[J]. Haematologica, 2008, 93:610-614.